BALCAO · SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC · SMALL CAP
Aesthetic Medical International Holdings Group Limited PAIYY
8 fiscal years on record · CNY · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
¥755.7M
▲ 10.7% vs FY2023
EPS · FY24
¥-0.14
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
-50.3%
Net margin · FY24
-2.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
CNY 755.7M
Revenue, FY2024 · full 8-year series below
Revenue
Net income
The company lost 3 cents on every revenue dollar this year.
Per share
CNY -0.14
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
-50.3%
Return on equity, FY2024
ROE
Operating margin—
Net margin-2.6%
Return on assets-3.8%
Each CNY of equity lost 50 cents this year.
Returned to shareholders
CNY 2.0M
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacksCNY 2.0M
Share of profit-10.1%
Consecutive raises—
CNY 2.0M in buybacks went back to shareholders in a year without profit.
Growth
−2.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.4%
−2.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
CNY 486.2M
total assets, end of FY2024
Total assetsCNY 486.2M
EquityCNY 30.5M
CashCNY 42.8M
Gross debtCNY 85.9M
Net debtCNY 43.1M
Net debt stands at 142% of equity.
History
8 fiscal years
Every figure from documents filed with the SEC · CNY
Metric
2024
2023
2022
2021
2020
2019
2018
2017
Revenue ¥B
0.8
0.7
0.7
0.6
0.9
0.9
0.8
0.7
Operating income ¥B
·
·
·
·
·
·
·
·
EBITDA ¥B
·
·
·
·
·
·
·
·
Income tax ¥B
0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
Net income ¥B
−0.0
−0.0
−0.1
−0.6
−0.2
0.1
−0.3
−0.1
EPS, diluted ¥
−0.14
−0.28
−0.93
−8.89
−3.61
−0.78
−6.22
−1.87
Dividend / sh ¥
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
ROE %
−50.3
·
·
−500.9
−50.2
101.3
·
·
Shares out B
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
30 of 30
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed